Past Event
日にち
July 30 - 2024年8月1日
Location
San Diego, CA
Targeted Radiopharmaceuticals Summit
We are excited to be presenting at this conference!
Wednesday, July 31st, 2024 at 12:15 PM PT
臨床薬理学とモデルを活かした医薬品開発 (MIDD) による 放射線療法の洞察
Joshua Apgar, PhD
|VP, Global Head of ABM Scientific Affairs
- Learn how clinical pharmacology considerations and model-informed drug development (MIDD) concepts help streamline therapeutic index-focused discovery and drug development for TRTs.
- Learn how to craft strategies that comply with the FDA’s Project Optimus initiative to optimize oncology drug dosage.
- Understand dose optimization requirements for TRT in the clinical pharmacology regulatory landscape.
- Discover how MIDD, including quantitative systems pharmacology (QSP) and pharmacometrics, help drive rational drug design, patient selection, and inform dosage optimization.
